# CVE-2023-25931: Medtronic Micro Clinician & InterStim X Clinician App Password Reset Issue

> Attackers with physical access can bypass password controls to gain unauthorized control over clinician therapy parameters in Medtronic apps.

- **Severity:** Medium 6.4 (`CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Not needed
- **Attackable:** Local or same network only
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 1 Mar 2023
- **Updated:** 7 Mar 2025
- **Also known as:** GHSA-crgr-72p3-3g72

## What is CVE-2023-25931?

CVE-2023-25931 is a medium-severity authentication bypass vulnerability in Medtronic InsterStim Applications, published on 1 Mar 2023. It can only be exploited from the same machine or local network, with no action from the victim.

### Official description

Medtronic identified that the Pelvic Health clinician apps, which are installed on the Smart Programmer mobile device, have a password vulnerability that requires a security update to fix. Not updating could potentially result in unauthorized control of the clinician therapy application, which has greater control over therapy parameters than the patient app.  Changes still cannot be made outside of the established therapy parameters of the programmer.  For unauthorized access to occur, an individual would need physical access to the Smart Programmer.

Weakness: CWE-287 (Improper Authentication), CWE-620 (Unverified Password Change)

## Which versions are affected by CVE-2023-25931?

It affects 2 products.


Products: Medtronic Interstim X Clinician, Medtronic Micro Clinician.

## How do I fix CVE-2023-25931?

No fix has been published for CVE-2023-25931 yet. Limit exposure of the affected software until one is available.

## Is CVE-2023-25931 being exploited?

There is no known exploitation of CVE-2023-25931 in the wild and no public exploit code.

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2023-25931 and fix it if it is affected.

What it is: CVE-2023-25931 is a medium-severity authentication bypass vulnerability in Medtronic InsterStim Applications, published on 1 Mar 2023. It can only be exploited from the same machine or local network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2023-25931 in the wild and no public exploit code.

Affected product: Medtronic InsterStim Applications. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2023-25931/ (Markdown: https://insights.sbomify.com/CVE-2023-25931/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2023-25931
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2023-25931
- OSV: https://osv.dev/vulnerability/CVE-2023-25931

---
From sbomify Insights: https://insights.sbomify.com/CVE-2023-25931/
Summaries are generated and may contain mistakes; the official description above is the record.